Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Single-cell sequencing reveals why some CAR-T therapies succeed while others fail

Single-cell sequencing reveals why some CAR-T therapies succeed while others fail

Early life exposure to PFAS associated with common childhood leukemia

Early life exposure to PFAS associated with common childhood leukemia

New strategy boosts natural killer cells to fight cancer

New strategy boosts natural killer cells to fight cancer

Study maps the evolution of myeloid leukemia in children with Down syndrome

Study maps the evolution of myeloid leukemia in children with Down syndrome

Cancer-linked mutations in the brain cells may drive Alzheimer’s disease

Cancer-linked mutations in the brain cells may drive Alzheimer’s disease

Targeting super-enhancer mechanisms offers new strategies for cancer therapy

Targeting super-enhancer mechanisms offers new strategies for cancer therapy

Pennsylvania town faces fallout from Trump's environmental rule rollback

Pennsylvania town faces fallout from Trump's environmental rule rollback

New target CD43 may improve leukemia immunotherapy outcomes

New target CD43 may improve leukemia immunotherapy outcomes

Damon Runyon supports young scientists driving cancer research innovation

Damon Runyon supports young scientists driving cancer research innovation

Study reveals immune aging differs significantly between men and women

Study reveals immune aging differs significantly between men and women

CAR T therapy induces remission in multiple autoimmune diseases

CAR T therapy induces remission in multiple autoimmune diseases

OICR funds four Ontario teams to develop next-generation cancer therapies

OICR funds four Ontario teams to develop next-generation cancer therapies

New clinical guidelines address blood clot prevention in pediatric patients

New clinical guidelines address blood clot prevention in pediatric patients

Future CAR therapy expands beyond T cells to treat diverse diseases

Future CAR therapy expands beyond T cells to treat diverse diseases

CIPHER-seq technology reveals how immune cells communicate during treatment

CIPHER-seq technology reveals how immune cells communicate during treatment

Study finds increasing rates of therapy-related acute myeloid leukemia

Study finds increasing rates of therapy-related acute myeloid leukemia

Lung cancer scans can reveal signs of other undiagnosed cancers

Lung cancer scans can reveal signs of other undiagnosed cancers

Lipid nanoparticles help CAR T cells melt pancreatic cancer barriers

Lipid nanoparticles help CAR T cells melt pancreatic cancer barriers

Study reveals CAR T approach for hard-to-treat solid tumors

Study reveals CAR T approach for hard-to-treat solid tumors

Immune cells use neurotransmitters to regulate health and disease

Immune cells use neurotransmitters to regulate health and disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.